Neurocrine Biosciences
NBIX
#1432
Rank
HK$94.58 B
Marketcap
HK$936.73
Share price
-0.86%
Change (1 day)
10.16%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): HK$3.90 B

According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are HK$3.89 B. In 2023 the company made an earning of HK$2.62 B an increase over its 2022 earnings that were of HK$1.72 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.90 B48.66%
2023 HK$2.62 B52.44%
2022 HK$1.72 B73.74%
2021 HK$0.99 B-8.82%
2020 HK$1.08 B77.78%
2019 HK$0.61 B49.83%
2018 HK$0.40 B-142.57%
2017 -HK$0.96 B-14.73%
2016 -HK$1.13 B53.15%
2015 -HK$0.74 B46.25%
2014 -HK$0.51 B29.66%
2013 -HK$0.39 B-3530.8%
2012 HK$11.28 M-95.73%
2011 HK$0.26 B
2009 -HK$0.38 B-45.38%
2008 -HK$0.69 B-58.87%
2007 -HK$1.66 B87.3%
2006 -HK$0.89 B351.97%
2005 -HK$0.2 B-52.09%
2004 -HK$0.41 B-10.98%
2003 -HK$0.46 B
2001 -HK$0.35 B
1999 -HK$0.16 B108.32%
1998 -HK$74.06 M
1996 HK$22.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.16 B-95.70%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$9.48 B 143.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$0.26 B-106.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$70.07 B 1,699.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$55.07 B 1,314.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.45 B-342.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.27 B-92.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.33 B-108.36%๐Ÿ‡บ๐Ÿ‡ธ USA